Spirometer Market Size, Share & Trends Analysis Report By Type (Hand Held, Table Top), By Technology (Volume Measurement, Flow Measurement), By Application (Asthma, COPD), By End-use, By Region, And Segment Forecasts, 2020 - 2027

Report Overview

The global spirometer market size was valued at USD 799.5 million in 2019 and is expected to expand at a compound annual growth rate (CAGR) of 9.7% from 2020 to 2027. An increase in the prevalence of chronic respiratory diseases, growing preference for home healthcare, and technological advancements are expected to drive the market. Around 2.0 billion people worldwide are exposed to air pollution regularly, both indoor and outdoor. Pollutants and irritants have various adverse effects on the lungs.

To simplify the complex procedure involved in pulmonary function testing for patients as well as medical professionals, companies are developing spirometers with improved design and features. The main objective is to develop spirometers with higher yield and improved patient comfort without complications. In addition, companies are also adopting innovative packaging procedures to prevent any type of bacterial infection. Such technological improvements make the testing procedures easier and simpler for patients.

The use of spirometry for asthma diagnosis is not frequent in pediatric patients especially in resource-poor countries where the burden of non-communicable diseases is higher. The strategies to increases the spirometry assessment frequency can reduce the burden of non-communicable diseases. The modern spirometry devices standardize test results and provide quick response, unlike conventional devices. The need for reduced hospital stay has been increasing due to the popularity of ambulatory care settings.

Preference for home healthcare has been increased over the past few years. The idea of providing treatment to patients in the comfort of their homes is a major factor propelling the growth of the market for a spirometer. The development of tele-spirometers is a result of the rising preference for home healthcare. Also, the increase in the geriatric population is driving the demand for home healthcare.

With the onset of COVID-19, the need to contain virus transmission lead to nationwide lockdowns globally and shut down of outpatient centers and other non-emergency settings. However, countries are now planning to reopen medical centers. For instance, Italy has entered phase 2 of this pandemic, wherein it is planning to reopen operations in the country. Respiratory units are planning to reopen its functions by employing certain measures, such as pulmonologist evaluation in a room with disinfected equipment and minimum furnish, a technician wearing a PPE suit, and use of disposable nose clips and mouthpiece.

Type Insights

The tabletop segment dominated the spirometer market and accounted for the largest revenue share of 43.5% in 2019. The market growth is characterized by extensive use in the diagnosis of obstructive airway disorders including asthma and other pulmonary diseases. On the other hand, the desktop spirometers segment is expected to register the fastest growth as they provide integrated clinical information for enhanced clinical decisions.

Portable spirometers that are lightweight and compact have become popular as these devices can store hundreds of diagnostic test results and can print the results on standard printers. Moreover, results can be transferred to flash drives as well as to patient’s Electronic Medical Records (EMRs).

Technology Insights

The flow measurement technology segment dominated the market for a spirometer and accounted for the largest revenue share of 66.7% in 2019. This is owing to its wide applications in pulmonary function testing. The peak flow measurement segment is expected to witness the fastest growth over the forecast period from 2020 to 2027. Peak flow measurement devices can provide warnings before an asthma attack by indicating the contraction of lung airways. Hence, medical care can be provided on time for asthma patients.

End-use Insights

The hospitals and clinics segment dominated the market for spirometer and accounted for the largest revenue share of 63.7% in 2019 as spirometry is extensively performed in hospitals and clinics for diagnosis and monitoring of chronic respiratory disorders. On the other hand, the home healthcare segment is expected to witness the fastest growth in the market for a spirometer over the forecast period. Homecare for patients with respiratory diseases reduces morbidity, improves the overall quality of life, and increases their chances of survival. The adoption of telemedicine and the launch of new products are factors likely to boost segment growth.

Application Insights

The COPD segment dominated the market for a spirometer and accounted for the largest revenue share of 39.8% in 2019. This is due to the high number of people suffering worldwide from mild to severe COPD. On the other hand, the asthma segment is expected to witness the fastest growth over the forecast period from 2020 to 2027.

The economic burden caused by asthma on the NHS is around 1 billion every year. The global prevalence of asthma among children is around 14% and the overall annual costs of asthma treatment in the U.S. are around USD 18 billion. However, the adoption of mobile applications such as ResAppDx-capable of diagnosing COPD and aggravations of COPD due to infections-can act as an alternative and limit the use of spirometers.

Regional Insights

North America dominated the market for spirometers and accounted for the largest revenue share of 42.2% in 2019. This is due to the high prevalence of Chronic Obstructive Pulmonary Disease (COPD) in the U.S. According to the CDC, the costs involved in the treatment of COPD are likely to reach USD 90 billion by 2020 from USD 59 billion in 2016. The Asia Pacific is expected to witness the fastest growth rate over the forecast period. Improving primary care initiatives for early diagnosis and management of chronic lung diseases such as asthma and COPD are expected to drive the market for spirometers in the Asia Pacific over the forecast period.

Key Companies & Market Share Insights

The market for spirometer consists of a combination of respiratory devices manufacturers and standalone spirometer manufacturers. New technological improvements such as the adoption of artificial intelligence will create growth opportunities for new players to enter the market. For instance, NuvoAir-a Swedish respiratory health startup-developed a technology platform that enables users to conduct at-home lung function assessments.

Companies are competing to acquire the market share, especially in technologically advanced nations such as the U.K., Germany, and the U.S. The market for spirometer has witnessed acquisitions and collaborations between market players to strengthen their presence. For instance, in January 2020, NuvoAir partnered with Roche Italy, wherein Roche will distribute NuvoAir’s digital respiratory technology to cystic fibrosis centers across Italy. This is expected to intensify the competition in the market over the forecast period. Some of the prominent players in the spirometer market include:

• Schiller

• Smiths Medical

• Vyaire Medical, Inc.

• SDI Diagnostics

• Nihon Kohden Corporation

• nSpire Health Inc.

• Fukuda Sangyo Co. Ltd.

• Sibelmed

• Labtech Ltd.

• Vitalograph

• Geratherm Respiratory AG

• Koninklijke Philips N.V.

• Welch Allyn

Spirometer Market Report Scope

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2027. For the purpose of this study, Grand View Research has segmented the global spirometer market report based on type, technology, application, end-use, and region:

• Type Outlook (Revenue, USD Million, 2016 - 2027)

  • Hand Held

  • Table Top

  • Desktop

• Technology Outlook (Revenue, USD Million, 2016 - 2027)

  • Volume Measurement

  • Flow Measurement

  • Peak Flow Measurement

• Application Outlook (Revenue, USD Million, 2016 - 2027)

  • Asthma

  • COPD

  • Cystic Fibrosis

  • Pulmonary Fibrosis

  • Others

• End-use Outlook (Revenue, USD Million, 2016 - 2027)

  • Hospitals and Clinics

  • Home Healthcare

• Regional Outlook (Revenue, USD Million, 2016 - 2027)

  • North America

    • U.S.

    • Canada

  • Europe

    • U.K.

    • Germany

    • France

    • Italy

    • Spain

  • Asia Pacific

    • Japan

    • China

    • India

  • Latin America

    • Brazil

    • Mexico

  • Middle East & Africa

    • South Africa